NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

A Bodansky, SE Vazquez, J Chou, T Novak… - Journal of Allergy and …, 2023 - Elsevier
Background Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …
被引用次数：17 相关文章

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications

A Bodansky, SE Vazquez, J Chou… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

Overcoming COVID-19 Network Study … - Journal of Allergy …, 2023 - experts.nebraska.edu
Background: Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.

A Bodansky, SE Vazquez, J Chou, T Novak, A Al-Musa… - 2023 - cabidigitallibrary.org
Background: Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …
[HTML] nih.gov

[HTML][HTML] NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

A Bodansky, SE Vazquez, J Chou, T Novak… - The Journal of Allergy …, 2023 - ncbi.nlm.nih.gov
Background Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …
[PDF] iupui.edu

[PDF][PDF] NFKB2 haploinsufficiency identified via screening for IFNα2 autoantibodies in children 1 and adolescents hospitalized with SARS-CoV-2-related complications …

A Bodansky, SE Vazquez, J Chou, T Novak, A Al-Musa… - scholarworks.iupui.edu
Background. Autoantibodies against type I interferons (IFNs) occur in approximately 10% of
77 adults with life-threatening COVID-19. The frequency of anti-IFN autoantibodies in …
[PDF] iu.edu

[PDF][PDF] NFKB2 haploinsufficiency identified via screening for IFNα2 autoantibodies in children 1 and adolescents hospitalized with SARS-CoV-2-related complications …

A Bodansky, SE Vazquez, J Chou, T Novak, A Al-Musa… - scholarworks.indianapolis.iu.edu
Background. Autoantibodies against type I interferons (IFNs) occur in approximately 10% of
77 adults with life-threatening COVID-19. The frequency of anti-IFN autoantibodies in …

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

A Bodansky, SE Vazquez, J Chou… - Journal of allergy …, 2023 - scholarship.miami.edu
Autoantibodies against type I IFNs occur in approximately 10% of adults with life-threatening
coronavirus disease 2019 (COVID-19). The frequency of anti-IFN autoantibodies in children …

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

A Bodansky, SE Vazquez, J Chou, T Novak… - Journal of Allergy and …, 2023 - jacionline.org
Background Autoantibodies against type I IFNs occur in approximately 10% of adults with
life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.

A Bodansky, S Vazquez, J Chou, T Novak… - Journal of Allergy and …, 2023 - escholarship.org
BACKGROUND: Autoantibodies against type I IFNs occur in approximately 10% of adults
with life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN …